Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

EQEquillium, Inc.

Nasdaq · CIK 0001746466
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts278

Identity from submissions API

NameEquillium, Inc.
CIK0001746466
TickersEQ
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN821554746
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(858) 412-5302
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
2223 AVENIDA DE LA PLAYA
SUITE 105
LA JOLLA
CA
92037
CA
Mailing address
2223 AVENIDA DE LA PLAYA
SUITE 105
LA JOLLA
CA
92037
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

472 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003588 333-300003 261576587 33 1750
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001346824-26-000279 005-90684 261562673 34 15348
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001011438-26-000692 005-90684 261552589 34 9893
2026-11-12 S-3 S-3 0001193125-26-458652 333-300003 261547851 33 409531 1 1
2026-11-12 10-Q 10-Q 0001193125-26-458443 001-38692 261547166 34 6917931 1 1
2026-11-12 8-K 8-K 2.02,9.01 0001193125-26-458379 001-38692 261547008 34 1229714 1 1
2026-11-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-007564 005-90684 261543917 34 13192
2026-11-04 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001716774-26-000029 005-90684 261520154 34 8940
2026-10-26 8-K 8-K 3.02,7.01,8.01,9.01 0001193125-26-432158 001-38692 261486666 34 181270 1 1
2026-10-05 8-K 8-K 8.01 0001193125-26-414364 001-38692 261441341 34 145427 1 1
2026-08-13 10-Q 10-Q 0001193125-26-349235 001-38692 261273615 34 6630953 1 1
2026-08-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001011438-26-000514 005-90684 261273457 34 15440
2026-08-13 8-K 8-K 2.02,9.01 0001193125-26-349182 001-38692 261273390 34 770694 1 1
2026-08-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-004991 005-90684 261266269 34 13065
2026-06-05 144 xsl144X01/primary_doc.xml 0001974158-26-000073 001-38692 261070180 33 4889
2026-06-05 4 xslF345X06/form4-06052026_080654.xml 0001797818-26-000011 9270
2026-06-05 4 xslF345X06/form4-06052026_080654.xml 0001746808-26-000004 7211
2026-06-04 144 xsl144X01/primary_doc.xml 0001974158-26-000071 001-38692 261066123 33 4245
2026-05-29 4 xslF345X06/form4-05292026_100546.xml 0002012180-26-000002 9232
2026-05-29 4 xslF345X06/form4-05292026_100505.xml 0001198230-26-000003 5613
2026-05-29 4 xslF345X06/form4-05292026_100506.xml 0001559569-26-000001 5645
2026-05-29 4 xslF345X06/form4-05292026_100514.xml 0001236397-26-000003 10705
2026-05-29 4 xslF345X06/form4-05292026_100515.xml 0001797818-26-000009 28182
2026-05-29 4 xslF345X06/form4-05292026_100553.xml 0001710696-26-000001 5641
2026-05-29 4 xslF345X06/form4-05292026_100513.xml 0001627886-26-000001 5642
2026-05-29 8-K 8-K 5.07,9.01 0001193125-26-248246 001-38692 261044307 34 158910 1 1
2026-05-27 144 xsl144X01/primary_doc.xml 0001970051-26-000014 001-38692 261026334 33 5095
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-062882 005-90684 26990491 34 14661
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001843384-26-000004 005-90684 26987555 34 15382
2026-05-13 10-Q 10-Q 0001193125-26-221625 001-38692 26973349 34 5912047 1 1
2026-05-13 8-K 8-K 2.02,9.01 0001193125-26-221595 001-38692 26973194 34 741258 1 1
2026-05-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001716774-26-000015 005-90684 26951653 34 8824
2026-04-16 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001220 333-294919 26869301 33 1749
2026-04-15 ARS ARS 0001193125-26-156107 001-38692 26862701 34 3597757
2026-04-15 DEFA14A DEFA14A 0001193125-26-156100 001-38692 26862686 34 321756
2026-04-15 DEF 14A DEF 14A 0001193125-26-156092 001-38692 26862669 34 8065112 1 1
2026-04-14 CORRESP filename1.htm 0001193125-26-154359 7471
2026-04-13 UPLOAD filename1.pdf 0000000000-26-003704 333-294919 40044
2026-04-07 S-3 S-3 0001193125-26-145746 333-294919 26845697 33 480458 1 1
2026-03-30 PRE 14A PRE 14A 0001193125-26-132029 001-38692 26813642 34 7943324 1 1
2026-03-25 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000928 333-291510 26794174 33 1749
2026-03-25 S-8 S-8 0001193125-26-124181 333-294599 26792833 33 182420 1 1
2026-03-25 10-K 10-K 0001193125-26-124143 001-38692 26792619 34 11692769 1 1
2026-03-25 8-K 8-K 2.02,9.01 0001193125-26-124107 001-38692 26792513 34 805492 1 1
2026-03-23 CORRESP filename1.htm 0001193125-26-120364 8272
2026-03-20 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001346824-26-000077 005-90684 26778379 34 19736
2026-03-16 4 xslF345X05/form4-03162026_100332.xml 0001797818-26-000008 9140
2026-03-13 144 xsl144X01/primary_doc.xml 0001970051-26-000005 001-38692 26752491 33 6394
2026-03-13 8-K 8-K 1.01,3.02,9.01 0001193125-26-105083 001-38692 26750145 34 593591 1 1
2026-03-11 4/A xslF345X05/form4a-03122026_120311.xml 0001797818-26-000006 9619
2026-03-11 4 xslF345X05/form4-03122026_120323.xml 0001797818-26-000004 16322
2026-03-09 144 xsl144X01/primary_doc.xml 0001970051-26-000004 001-38692 26734972 33 8659
2026-02-23 4 xslF345X05/form4-02232026_050246.xml 0001797818-26-000003 13757
2026-02-19 144 xsl144X01/primary_doc.xml 0001970051-26-000003 001-38692 26654243 33 7583
2026-02-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-26-000047 005-90684 26608177 34 12801
2026-01-09 4 xslF345X05/form4-01092026_100131.xml 0001746808-26-000002 5469
2026-01-09 4 xslF345X05/form4-01092026_100145.xml 0001797818-26-000001 5476
2026-01-09 4 xslF345X05/form4-01092026_100147.xml 0001614997-26-000001 5489
2026-01-09 4 xslF345X05/form4-01092026_100107.xml 0002012180-26-000001 7132
2026-01-08 144 xsl144X01/primary_doc.xml 0001970051-26-000001 001-38692 26518337 33 4431
2025-12-23 4 xslF345X05/form4-12232025_091202.xml 0001797818-25-000007 8654
2025-12-23 144 xsl144X01/primary_doc.xml 0001970051-25-000042 001-38692 251600812 33 6389
2025-12-15 4 xslF345X05/form4-12152025_101234.xml 0001797818-25-000005 6302
2025-12-12 144 xsl144X01/primary_doc.xml 0001970051-25-000039 001-38692 251567979 33 5642
2025-12-08 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000335 005-90684 251555158 34 9888
2025-11-25 4 xslF345X05/form4-11252025_111128.xml 0001797818-25-000003 6300
2025-11-25 144 xsl144X01/primary_doc.xml 0001970051-25-000037 001-38692 251518901 33 4455
2025-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-112816 005-90684 251488935 34 19303
2025-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-005036 005-90684 251486596 34 8844
2025-11-13 S-3 S-3 0001193125-25-280396 333-291510 251479451 33 1286140 1 1
2025-11-13 10-Q 10-Q 0001193125-25-280202 001-38692 251478704 34 8250698 1 1
2025-11-13 8-K 8-K 2.02,9.01 0001193125-25-280173 001-38692 251478534 34 787306 1 1
2025-11-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-004896 005-90684 251475768 34 16581
2025-10-24 8-K/A 8-K/A 4.01 0001193125-25-249953 001-38692 251416186 34 164420 1 1
2025-10-06 8-K 8-K 4.01,5.02,8.01,9.01 0001193125-25-231860 001-38692 251376876 34 166459 1 1
2025-09-19 8-K 8-K 8.01,9.01 0001193125-25-209068 001-38692 251326897 34 159216 1 1
2025-09-19 424B5 424B5 0001193125-25-209063 333-269153 251326839 33 14405
2025-09-18 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003008 333-290138 251324848 33 1750
2025-09-16 CORRESP filename1.htm 0001193125-25-204906 7550
2025-09-16 UPLOAD filename1.pdf 0000000000-25-010000 001-38692 39609
2025-09-11 UPLOAD filename1.pdf 0000000000-25-009869 333-290138 40048
2025-09-11 CORRESP filename1.htm 0001193125-25-200866 11962
2025-09-09 S-8 S-8 0001193125-25-199243 333-290140 251303954 33 522863 1 1
2025-09-09 S-3 S-3 0001193125-25-199239 333-290138 251303917 33 361987 1 1
2025-09-08 UPLOAD filename1.pdf 0000000000-25-009692 001-38692 43624
2025-09-04 8-K 8-K 8.01 0000950170-25-113023 001-38692 251293301 34 155160 1 1
2025-09-03 4 xslF345X05/form4-09032025_090928.xml 0001415889-25-023570 5497
2025-09-03 4 xslF345X05/form4-09032025_090942.xml 0001415889-25-023569 5446
2025-09-03 4 xslF345X05/form4-09032025_090933.xml 0001415889-25-023567 5493
2025-09-03 4 xslF345X05/form4-09032025_080901.xml 0001415889-25-023566 5484
2025-08-14 10-Q 10-Q 0000950170-25-108834 001-38692 251218533 34 8389188 1 1
2025-08-11 8-K 8-K 1.01,3.02,7.01,9.01 0001193125-25-177510 001-38692 251200335 34 649043 1 1
2025-08-04 8-K 8-K 1.01,2.02,7.01,8.01,9.01 0001193125-25-172207 001-38692 251178240 34 530308 1 1
2025-07-08 144 xsl144X01/primary_doc.xml 0001970051-25-000020 001-38692 251110002 33 4956
2025-06-13 8-K 8-K 3.01 0000950170-25-086155 001-38692 251046494 34 160992 1 1
2025-06-12 144 xsl144X01/primary_doc.xml 0001950047-25-004221 001-38692 251042861 33 4787
2025-05-23 4 xslF345X05/form4-05232025_050539.xml 0001415889-25-014400 5530
2025-05-23 4 xslF345X05/form4-05232025_050551.xml 0001415889-25-014399 5475
2025-05-23 4 xslF345X05/form4-05232025_050525.xml 0001415889-25-014398 5507
2025-05-23 4 xslF345X05/form4-05232025_050527.xml 0001415889-25-014397 5502
2025-05-23 4 xslF345X05/form4-05232025_050527.xml 0001415889-25-014396 5504
2025-05-23 4 xslF345X05/form4-05232025_050515.xml 0001415889-25-014395 5464
2025-05-22 8-K 8-K 5.02,5.07,9.01 0001193125-25-125153 001-38692 25978253 34 325202 1 1
2025-05-14 10-Q 10-Q 0000950170-25-071389 001-38692 25945555 34 7091457 1 1
2025-04-30 DEFR14A DEFR14A 0000950170-25-060573 001-38692 25890995 34 8380614 1 1
2025-04-24 8-K 8-K 2.02,9.01 0001193125-25-092435 001-38692 25863879 34 171088 1 1
2025-04-10 ARS ARS 0000950170-25-052671 001-38692 25826480 34 13712336
2025-04-10 DEFA14A DEFA14A 0000950170-25-052670 001-38692 25826469 34 2359771
2025-04-10 DEF 14A DEF 14A 0000950170-25-052669 001-38692 25826450 34 5025503
2025-03-28 PRE 14A PRE 14A 0000950170-25-046333 001-38692 25781438 34 4932458
2025-03-27 10-K 10-K 0000950170-25-045726 001-38692 25775250 34 27164930 1 1
2025-03-27 8-K 8-K 2.02,9.01 0000950170-25-045723 001-38692 25775235 34 805081 1 1
2025-02-19 4 xslF345X05/form4-02202025_120255.xml 0001415889-25-004763 29508
2025-02-19 4 xslF345X05/form4-02202025_120238.xml 0001415889-25-004762 29509
2025-02-19 4 xslF345X05/form4-02202025_120229.xml 0001415889-25-004761 29625
2025-02-19 4 xslF345X05/form4-02202025_120249.xml 0001415889-25-004760 33782
2025-02-19 4 xslF345X05/form4-02202025_120216.xml 0001415889-25-004759 21866
2025-02-19 4 xslF345X05/form4-02202025_120224.xml 0001415889-25-004758 21816
2025-02-19 4 xslF345X05/form4-02202025_120250.xml 0001415889-25-004757 26206
2025-02-19 4 xslF345X05/form4-02202025_120235.xml 0001415889-25-004756 25231
2025-02-19 4 xslF345X05/form4-02202025_120220.xml 0001415889-25-004755 29455
2025-02-19 4 xslF345X05/form4-02202025_120257.xml 0001415889-25-004754 8068
2025-02-06 8-K 8-K 8.01 0001193125-25-021348 001-38692 25595518 34 293749 1 1
2025-01-24 4 xslF345X05/form4-01242025_110117.xml 0001415889-25-002070 5990
2025-01-06 4 xslF345X05/form4-01062025_110145.xml 0001415889-25-000858 5475
2025-01-06 4 xslF345X05/form4-01062025_110153.xml 0001415889-25-000856 5500
2025-01-06 4 xslF345X05/form4-01062025_110151.xml 0001415889-25-000852 5498
2025-01-06 4 xslF345X05/form4-01062025_110147.xml 0001415889-25-000843 7930
2025-01-06 4 xslF345X05/form4-01062025_110148.xml 0001415889-25-000841 5495
2025-01-06 4 xslF345X05/form4-01062025_110104.xml 0001415889-25-000838 5496
2024-12-13 8-K 8-K 3.01 0001193125-24-278465 001-38692 241548324 34 147915 1 1
2024-12-12 4 xslF345X05/form4-12122024_101224.xml 0001415889-24-029164 5393
2024-12-12 3 xslF345X02/form3-12122024_101207.xml 0001415889-24-029163 10130
2024-12-12 8-K 8-K 5.02 0001193125-24-277043 001-38692 241544920 34 147591 1 1
2024-11-15 4 xslF345X05/form4-11152024_111115.xml 0001415889-24-026987 5991
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-119446 005-90684 241465684 34 115022
2024-11-14 144 xsl144X01/primary_doc.xml 0001950047-24-008564 001-38692 241462730 33 5537
2024-11-13 10-Q 10-Q 0000950170-24-126322 001-38692 241454257 34 7931478 1 1
2024-11-13 8-K 8-K 2.02,9.01 0000950170-24-126288 001-38692 241453973 34 746753 1 1
2024-10-31 144 xsl144X01/primary_doc.xml 0001970051-24-000044 001-38692 241413988 33 4301
2024-10-31 8-K 8-K 8.01,9.01 0001193125-24-248138 001-38692 241412395 34 11275280 1 1
2024-10-31 8-K 8-K 8.01 0001193125-24-247760 001-38692 241411866 34 145240 1 1
2024-10-30 4 xslF345X05/form4-10312024_121034.xml 0001415889-24-025804 4999
2024-10-29 4 xslF345X05/form4-10292024_041001.xml 0001415889-24-025695 6256
2024-09-27 4 xslF345X05/form4-09272024_110919.xml 0001415889-24-024079 5991
2024-09-17 4 xslF345X05/form4-09172024_100911.xml 0001415889-24-023546 5453
2024-08-08 10-Q 10-Q 0000950170-24-093949 001-38692 241188378 34 8021456 1 1
2024-08-08 8-K 8-K 2.02,9.01 0000950170-24-093884 001-38692 241188143 34 746943 1 1
2024-07-23 8-K 8-K 3.01 0001193125-24-182856 001-38692 241134462 34 145710 1 1
2024-07-18 4 xslF345X05/form4-07182024_090731.xml 0001415889-24-019776 6199
2024-07-18 8-K 8-K 2.02 0001193125-24-180952 001-38692 241124442 34 148655 1 1
2024-07-16 144 xsl144X01/primary_doc.xml 0001950047-24-005446 001-38692 241119928 33 4793
2024-06-04 8-K 8-K 8.01,9.01 0001193125-24-153667 001-38692 241016109 34 4242386 1 1
2024-05-23 4 xslF345X05/form4-05232024_100518.xml 0001415889-24-014372 5486
2024-05-23 4 xslF345X05/form4-05232024_100533.xml 0001415889-24-014370 5526
2024-05-23 4 xslF345X05/form4-05232024_100515.xml 0001415889-24-014369 5484
2024-05-23 4 xslF345X05/form4-05232024_090548.xml 0001415889-24-014367 5522
2024-05-23 4 xslF345X05/form4-05232024_090523.xml 0001415889-24-014364 5590
2024-05-23 4 xslF345X05/form4-05232024_090501.xml 0001415889-24-014358 5527
2024-05-23 8-K 8-K 5.07 0000950170-24-064016 001-38692 24979385 34 200860 1 1
2024-05-09 10-Q 10-Q 0000950170-24-056960 001-38692 24930696 34 7877073 1 1
2024-05-09 8-K 8-K 2.02,9.01 0000950170-24-056890 001-38692 24930436 34 711886 1 1
2024-04-11 ARS ARS 0001193125-24-093216 001-38692 24838605 34 3215401
2024-04-11 DEFA14A DEFA14A 0001193125-24-093202 001-38692 24838572 34 73323
2024-04-11 DEF 14A DEF 14A 0001193125-24-093200 001-38692 24838560 34 1554609
2024-04-01 PRE 14A PRE 14A 0001193125-24-083574 001-38692 24810740 34 1548780
2024-04-01 8-K 8-K 8.01 0001193125-24-082709 001-38692 24805639 34 158689 1 1
2024-03-25 S-8 S-8 0001193125-24-076531 333-278213 24779547 33 93639
2024-03-25 10-K 10-K 0000950170-24-035919 001-38692 24779323 34 19566790 1 1
2024-03-25 8-K 8-K 2.02,9.01 0001193125-24-076471 001-38692 24779214 34 227064 1 1
2024-03-08 3 xslF345X02/form3-03082024_100338.xml 0001415889-24-007392 19794
2024-03-08 8-K 8-K 5.02,8.01,9.01 0001193125-24-063618 001-38692 24734195 34 383800 1 1
2024-02-23 8-K 8-K 2.02,8.01,9.01 0001193125-24-044664 001-38692 24672539 34 176694 1 1
2024-02-23 424B5 424B5 0001193125-24-044660 333-269153 24672499 33 16695
2024-02-22 8-K 8-K 8.01 0001193125-24-041994 001-38692 24662176 34 144301 1 1
2024-01-19 SC 13G SC 13G 0001395064-24-000004 005-90684 24543638 34 75617
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000532 5570
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000529 5571
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000523 5569
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000518 8938
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000516 8967
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000515 9642
2023-12-21 8-K 8-K 8.01 0001193125-23-300417 001-38692 231502850 34 156734 1 1
2023-11-08 10-Q 10-Q 0000950170-23-061108 001-38692 231387931 34 8529669 1 1
2023-11-08 8-K 8-K 2.02,8.01,9.01 0000950170-23-061084 001-38692 231387739 34 844887 1 1
2023-10-16 8-K 8-K 7.01,8.01,9.01 0001193125-23-256538 001-38692 231326253 34 21939546 1 1
2023-10-05 8-K 8-K 1.01,1.02,3.01,9.01 0001193125-23-251681 001-38692 231312241 34 435825 1 1
2023-10-05 424B5 424B5 0001193125-23-251676 333-269153 231312196 33 420318
2023-08-09 10-Q 10-Q 0000950170-23-040583 001-38692 231155266 34 9932916 1 1
2023-08-09 8-K 8-K 2.02,9.01 0000950170-23-040564 001-38692 231155136 34 835084 1 1
2023-05-25 8-K 8-K 1.02 0001193125-23-154186 001-38692 23960341 34 146886 1 1
2023-05-23 4 FORM 4 SUBMISSION 0001209191-23-031724 5512
2023-05-23 4 FORM 4 SUBMISSION 0001209191-23-031720 5476
2023-05-23 4 FORM 4 SUBMISSION 0001209191-23-031713 5446
2023-05-23 4 FORM 4 SUBMISSION 0001209191-23-031707 5452
2023-05-23 4 FORM 4 SUBMISSION 0001209191-23-031706 5403
2023-05-23 4 FORM 4 SUBMISSION 0001209191-23-031704 5416
2023-05-23 8-K 8-K 5.07 0001193125-23-151783 001-38692 23948914 34 160680 1 1
2023-05-11 10-Q 10-Q 0000950170-23-021236 001-38692 23911112 34 8396690 1 1
2023-05-11 8-K 8-K 2.02,9.01 0000950170-23-021215 001-38692 23910934 34 589185 1 1
2023-04-13 ARS ARS 0001193125-23-100528 001-38692 23818441 34 32749096
2023-04-13 DEFA14A DEFA14A 0001193125-23-100513 001-38692 23818370 34 336235
2023-04-11 DEF 14A DEF 14A 0001193125-23-097790 001-38692 23813408 34 656878
2023-04-06 8-K 8-K 3.01 0001193125-23-093949 001-38692 23806151 34 153709 1 1
2023-03-31 PRE 14A PRE 14A 0001193125-23-087996 001-38692 23787408 34 654655
2023-03-23 10-K 10-K 0000950170-23-009492 001-38692 23756358 34 24588836 1 1
2023-03-23 8-K 8-K 2.02,9.01 0001193125-23-077853 001-38692 23756218 34 274010 1 1
2023-03-03 SC 13G/A equillium13ga5_022823.htm 0001040188-23-000057 005-90684 23701936 34 43930
2023-02-23 RW RW 0001193125-23-046500 333-268024 23659503 NE 7077
2023-02-07 4 FORM 4 SUBMISSION 0001209191-23-007681 5456
2023-02-07 4 FORM 4 SUBMISSION 0001209191-23-007679 5454
2023-02-07 4 FORM 4 SUBMISSION 0001209191-23-007678 5413
2023-02-07 4 FORM 4 SUBMISSION 0001209191-23-007677 5429
2023-02-07 4 FORM 4 SUBMISSION 0001209191-23-007672 5457
2023-02-07 4 FORM 4 SUBMISSION 0001209191-23-007671 5456
2023-01-31 SC 13G/A equillium13ga4_123122.htm 0001040188-23-000005 005-90684 23570521 34 43933
2023-01-18 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-01-18 16:30:00 9999999995-23-000126 333-269153 23535831 33 1707
2023-01-13 CORRESP filename1.htm 0001193125-23-008341 8266
2023-01-12 UPLOAD filename1.pdf 0000000000-23-000352 40203
2023-01-06 S-8 S-8 0001193125-23-003658 333-269154 23515908 33 78741
2023-01-06 S-3 S-3 0001193125-23-003655 333-269153 23515882 33 954511
2023-01-04 4 FORM 4 SUBMISSION 0001209191-23-001374 5456
2023-01-04 4 FORM 4 SUBMISSION 0001209191-23-001369 5455
2023-01-04 4 FORM 4 SUBMISSION 0001209191-23-001367 7965
2023-01-04 4 FORM 4 SUBMISSION 0001209191-23-001366 8823
2023-01-04 4 FORM 4 SUBMISSION 0001209191-23-001364 5457
2023-01-04 4 FORM 4 SUBMISSION 0001209191-23-001362 7289
2022-12-23 8-K 8-K 1.02,5.07,8.01,9.01 0001193125-22-311788 001-38692 221485490 34 181384 1 1
2022-12-15 425 425 0001193125-22-305080 001-38692 221463550 34 197454
2022-12-15 8-K 8-K 8.01 0001193125-22-305076 001-38692 221463539 34 463387 1 1
2022-12-06 425 425 0001193125-22-299461 001-38692 221448290 34 115538
2022-12-06 425 425 0001193125-22-298872 001-38692 221446680 34 4703078
2022-12-06 8-K 8-K 1.01,8.01,9.01 0001193125-22-298869 001-38692 221446675 34 4854051 1 1
2022-11-14 10-Q 10-Q 0000950170-22-025052 001-38692 221387703 34 9043556 1 1
2022-11-14 425 425 0001193125-22-284618 001-38692 221385794 34 83240
2022-11-14 8-K 8-K 2.02,9.01 0000950170-22-024988 001-38692 221385283 34 961874 1 1
2022-11-10 EFFECT xslEFFECTX01/primary_doc.xml S-4,,2022-11-10 16:00:00 9999999995-22-003274 333-268024 221379425 33 1708
2022-11-10 424B3 424B3 0001140361-22-040932 333-268024 221377328 33 4011669
2022-11-09 CORRESP filename1.htm 0001140361-22-040709 10267
2022-11-09 S-4/A FORM S-4/A 0001140361-22-040707 333-268024 221373192 33 4944482
2022-11-01 UPLOAD filename1.pdf 0000000000-22-011918 40178
2022-10-27 S-4 S-4 0001140361-22-038559 333-268024 221334696 33 4530729
2022-09-28 425 425 0001193125-22-252495 110589
2022-09-27 425 425 0001193125-22-251808 16280078
2022-09-27 8-K 8-K 8.01,9.01 0001193125-22-251807 001-38692 221267503 34 16435560 1 1
2022-09-26 425 425 0001193125-22-251387 1089068
2022-09-26 8-K 8-K 8.01,9.01 0001193125-22-251386 001-38692 221266812 34 1342710 1 1
2022-09-07 425 425 0001193125-22-240106 214847
2022-09-06 425 425 0001193125-22-238897 001-38692 221228664 34 5979923
2022-09-06 8-K 8-K 1.01,8.01,9.01 0001193125-22-238883 001-38692 221228596 34 6247334 1 1
2022-08-30 4 FORM 4 SUBMISSION 0001209191-22-048037 6116
2022-08-15 10-Q 10-Q 0000950170-22-017399 001-38692 221166358 34 8395336 1 1
2022-08-15 8-K 8-K 2.02,9.01 0000950170-22-017382 001-38692 221165941 34 921418 1 1
2022-06-06 4 FORM 4 SUBMISSION 0001209191-22-034749 5910
2022-05-25 4 FORM 4 SUBMISSION 0001209191-22-031995 5480
2022-05-25 4 FORM 4 SUBMISSION 0001209191-22-031994 5414
2022-05-25 4 FORM 4 SUBMISSION 0001209191-22-031993 5420
2022-05-25 4 FORM 4 SUBMISSION 0001209191-22-031992 5371
2022-05-25 4 FORM 4 SUBMISSION 0001209191-22-031991 5384
2022-05-25 8-K 8-K 5.07 0001193125-22-159792 001-38692 22963838 34 154536 1 1
2022-05-12 10-Q 10-Q 0000950170-22-009669 001-38692 22917934 34 7865188 1 1
2022-05-12 8-K 8-K 2.02,9.01 0000950170-22-009653 001-38692 22917812 34 897052 1 1
2022-05-09 8-K 8-K 8.01 0001193125-22-144343 001-38692 22903320 34 167872 1 1
2022-05-02 8-K/A 8-K/A 9.01 0000950170-22-006823 001-38692 22880723 34 2632558 1 1
2022-04-25 8-K 8-K 8.01 0001193125-22-116380 001-38692 22847373 34 166839 1 1
2022-04-13 DEFA14A DEFA14A 0001193125-22-104274 001-38692 22824798 34 58455
2022-04-13 DEF 14A DEF 14A 0001193125-22-104267 001-38692 22824771 34 483184
2022-04-05 4 FORM 4 SUBMISSION 0001209191-22-023220 5912
2022-03-23 S-8 S-8 0001193125-22-082766 333-263790 22763472 33 65112
2022-03-23 10-K 10-K 0000950170-22-004407 001-38692 22763300 34 17019951 1 1
2022-03-23 8-K 8-K 2.02,9.01 0000950170-22-004404 001-38692 22763213 34 671323 1 1
2022-03-08 4 FORM 4 SUBMISSION 0001209191-22-017194 5292
2022-03-08 3 FORM 3 SUBMISSION 0001209191-22-017184 6028
2022-03-04 8-K 8-K 7.01,9.01 0000950170-22-002895 001-38692 22713413 34 497430 1 1
2022-03-02 8-K 8-K 5.02,8.01,9.01 0000950170-22-002622 001-38692 22701513 34 488625 1 1
2022-02-16 8-K 8-K 1.01,2.01,2.03,3.02,7.01,8.01,9.01 0001193125-22-043939 001-38692 22641475 34 13190489 1 1
2022-02-14 SC 13G SC 13G 0001104659-22-022123 005-90684 22627716 34 42910
2022-02-01 SC 13G/A equillium13ga3_123121.htm 0001040188-22-000016 005-90684 22577827 34 43965
2021-12-13 4 FORM 4 SUBMISSION 0001209191-21-069177 5471
2021-12-13 4 FORM 4 SUBMISSION 0001209191-21-069176 4735
2021-12-03 4 FORM 4 SUBMISSION 0001209191-21-067752 5819
2021-11-17 4 FORM 4 SUBMISSION 0001209191-21-065041 15089
2021-11-10 10-Q 10-Q 0000950170-21-004079 001-38692 211396700 34 6606494 1 1
2021-11-10 8-K 8-K 2.02,9.01 0000950170-21-004068 001-38692 211396508 34 907354 1 1
2021-10-07 4 FORM 4 SUBMISSION 0001209191-21-060004 15568
2021-09-29 4 FORM 4 SUBMISSION 0001209191-21-058029 5819
2021-08-10 10-Q 10-Q 0000950170-21-001180 001-38692 211160122 34 6003642 1 1
2021-08-10 8-K 8-K 2.02,9.01 0000950170-21-001177 001-38692 211160010 34 879650 1 1
2021-07-28 4 FORM 4 SUBMISSION 0001209191-21-048405 5818
2021-07-12 8-K 8-K 7.01,9.01 0000950170-21-000445 001-38692 211085552 34 747067 1 1
2021-06-14 4 FORM 4 SUBMISSION 0001209191-21-040316 4828
2021-06-14 4 FORM 4 SUBMISSION 0001209191-21-040314 4784
2021-06-14 4 FORM 4 SUBMISSION 0001209191-21-040313 4803
2021-06-14 8-K 8-K 8.01 0000950170-21-000348 001-38692 211014529 34 170279 1 1
2021-06-11 8-K 8-K 7.01,9.01 0000950170-21-000344 001-38692 211009944 34 783400 1 1
2021-06-10 8-K 8-K 7.01,9.01 0000950170-21-000338 001-38692 211007307 34 463702 1 1
2021-06-09 4 FORM 4 SUBMISSION 0001209191-21-039081 32205
2021-06-07 8-K 8-K 7.01,9.01 0000950170-21-000318 001-38692 21999285 34 749724 1 1
2021-05-28 4/A FORM 4/A SUBMISSION 0001209191-21-036674 6034
2021-05-28 4 FORM 4 SUBMISSION 0001209191-21-036648 5386
2021-05-28 4 FORM 4 SUBMISSION 0001209191-21-036641 5624
2021-05-28 4 FORM 4 SUBMISSION 0001209191-21-036639 5630
2021-05-28 4 FORM 4 SUBMISSION 0001209191-21-036637 5581
2021-05-28 4 FORM 4 SUBMISSION 0001209191-21-036635 5593
2021-05-28 8-K 8-K 5.07 0000950123-21-007391 001-38692 21976564 34 177515 1 1
2021-05-13 10-Q 10-Q 0000950170-21-000224 001-38692 21919864 34 5588337 1 1
2021-05-13 8-K 8-K 2.02,9.01 0000950170-21-000223 001-38692 21919777 34 553809 1 1
2021-04-09 DEFA14A DEFA14A 0001564590-21-018339 001-38692 21817986 34 233363
2021-04-09 DEF 14A DEF 14A 0001564590-21-018327 001-38692 21817852 34 895595
2021-03-30 8-K 8-K 7.01,9.01 0001564590-21-016669 001-38692 21786934 34 468681
2021-03-24 S-8 2021 S-8 (EVERGREEN) 0001564590-21-015107 333-254656 21768443 33 129983
2021-03-24 10-K 10-K 0001564590-21-015103 001-38692 21768388 34 15238289 1
2021-03-24 8-K 2020 YE 8-K 2.02,9.01 0001564590-21-015101 001-38692 21768325 34 488660
2021-03-15 8-K 8-K 7.01,9.01 0001564590-21-013009 001-38692 21739878 34 92640
2021-03-09 8-K FORM 8-K 7.01,9.01 0001564590-21-011597 001-38692 21724057 34 3497956
2021-03-05 4 FORM 4 SUBMISSION 0001209191-21-018214 5307
2021-02-16 3 OWNERSHIP DOCUMENT 0001104659-21-024391 9471
2021-02-16 SC 13D SC 13D 0001104659-21-024389 005-90684 21640957 34 126855
2021-02-12 8-K FORM 8-K 7.01,9.01 0001564590-21-005752 001-38692 21626186 34 1340367
2021-02-05 3 FORM 3 SUBMISSION 0001209191-21-008066 7102
2021-02-04 8-K 8-K 1.01,5.02,8.01,9.01 0001564590-21-004194 001-38692 21588916 34 287218
2021-02-04 424B5 424B5 0001193125-21-028129 333-234683 21588909 33 415402
2021-02-03 SC 13G/A equillium13ga2_123120.htm 0001040188-21-000043 005-90684 21584617 34 43918
2021-01-29 3 FORM 3 SUBMISSION 0001209191-21-006207 12849
2021-01-13 4 FORM 4 SUBMISSION 0001209191-21-003422 5438
2021-01-13 3 FORM 3 SUBMISSION 0001209191-21-003420 7093
2021-01-06 4 FORM 4 SUBMISSION 0001209191-21-002168 5445
2021-01-06 4 FORM 4 SUBMISSION 0001209191-21-002167 5447
2021-01-06 4 FORM 4 SUBMISSION 0001209191-21-002166 5447
2021-01-06 4 FORM 4 SUBMISSION 0001209191-21-002165 5404
2021-01-06 4 FORM 4 SUBMISSION 0001209191-21-002164 5448
2020-12-30 4 FORM 4 SUBMISSION 0001209191-20-065537 5275
2020-12-28 4 FORM 4 SUBMISSION 0001209191-20-065139 5952
2020-12-21 8-K 8-K 1.01,5.02,7.01,9.01 0001193125-20-322379 001-38692 201402437 34 94024
2020-12-11 4 FORM 4 SUBMISSION 0001209191-20-062993 5403
2020-12-11 4 FORM 4 SUBMISSION 0001209191-20-062992 4700
2020-12-07 8-K 8-K 7.01,9.01 0001193125-20-311281 001-38692 201371517 34 39074
2020-12-04 8-K 8-K 7.01,9.01 0001193125-20-310114 001-38692 201368822 34 48398943
2020-11-30 8-K 8-K 7.01,9.01 0001193125-20-304969 001-38692 201356314 34 36810
2020-11-25 8-K 8-K 7.01,9.01 0001193125-20-303087 001-38692 201346869 34 34469
2020-11-10 10-Q 10-Q 0001564590-20-052979 001-38692 201301339 34 6375345 1
2020-11-10 8-K 8-K 2.02,9.01 0001193125-20-290153 001-38692 201301234 34 73160
2020-10-29 8-K FORM 8-K 8.01,9.01 0001193125-20-281174 001-38692 201273639 34 37875
2020-09-30 4 FORM 4 SUBMISSION 0001209191-20-052467 5276
2020-09-28 8-K 8-K 5.02,9.01 0001193125-20-256711 001-38692 201205183 34 33259
2020-08-14 8-K 8-K 1.01,8.01,9.01 0001193125-20-220538 001-38692 201106175 34 334743
2020-08-14 424B5 424B5 0001193125-20-220489 333-234683 201106085 33 487955
2020-08-13 424B5 424B5 0001193125-20-219125 333-234683 201099261 33 492053
2020-08-12 10-Q 10-Q 0001564590-20-039503 001-38692 201094242 34 6092226 1
2020-08-12 8-K 8-K 2.02,9.01 0001193125-20-217090 001-38692 201094233 34 63019
2020-08-10 8-K 8-K 7.01,8.01,9.01 0001193125-20-215058 001-38692 201090393 34 63076
2020-07-15 4 FORM 4 SUBMISSION 0001209191-20-042499 5277
2020-07-14 8-K 8-K 1.01,9.01 0001193125-20-192229 001-38692 201026267 34 238637
2020-07-14 424B5 424B5 0001193125-20-192218 333-234683 201026260 33 398413
2020-07-13 8-K 8-K 8.01,9.01 0001193125-20-191424 001-38692 201024241 34 39525
2020-06-12 4 FORM 4 SUBMISSION 0001209191-20-036285 5401
2020-06-12 4 FORM 4 SUBMISSION 0001209191-20-036284 4699
2020-06-01 8-K 8-K 5.02 0001193125-20-156556 001-38692 20930981 34 17884
2020-05-29 4 FORM 4 SUBMISSION 0001209191-20-032939 5137
2020-05-29 4 FORM 4 SUBMISSION 0001209191-20-032938 5088
2020-05-29 4 FORM 4 SUBMISSION 0001209191-20-032937 5189
2020-05-29 4 FORM 4 SUBMISSION 0001209191-20-032936 5190
2020-05-21 4 FORM 4 SUBMISSION 0001209191-20-031278 5442
2020-05-21 4 FORM 4 SUBMISSION 0001209191-20-031277 5421
2020-05-21 4 FORM 4 SUBMISSION 0001209191-20-031276 5442
2020-05-21 4 FORM 4 SUBMISSION 0001209191-20-031275 5415
2020-05-21 4 FORM 4 SUBMISSION 0001209191-20-031274 5372
2020-05-21 4 FORM 4 SUBMISSION 0001209191-20-031273 5385
2020-05-21 8-K 8-K 2020 ANNUAL MTG RESULTS 5.07 0001564590-20-026454 001-38692 20900032 34 54864
2020-05-13 10-Q 10-Q 0001564590-20-025063 001-38692 20873359 34 5120805 1
2020-05-13 8-K 8-K Q1 2020 EARNINGS RELEASE 2.02,9.01 0001564590-20-025054 001-38692 20873255 34 158101
2020-04-24 4 FORM 4 SUBMISSION 0001209191-20-025659 12875
2020-04-24 4 FORM 4 SUBMISSION 0001209191-20-025656 17743
2020-04-24 4 FORM 4 SUBMISSION 0001209191-20-025655 17717
2020-04-24 8-K 8-K 5.02 0001564590-20-018536 001-38692 20815467 34 41127
2020-04-07 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-04-07 16:30:00 9999999995-20-000701 333-237491 20781001 33 1707
2020-04-07 424B3 424B3 0001564590-20-015736 333-237491 20780295 33 295323
2020-04-03 CORRESP filename1.htm 0001564590-20-015267 19433
2020-04-03 DEF 14A DEF 14A 0001564590-20-015262 001-38692 20773522 34 837817
2020-04-02 UPLOAD filename1.pdf 0000000000-20-002854 39857
2020-03-30 S-1 S-1 (ELOC) 0001564590-20-014306 333-237491 20758548 33 547931
2020-03-30 8-K 8-K (ELOC) 1.01,3.02,9.01 0001564590-20-014185 001-38692 20757214 34 536217
2020-03-26 S-8 S-8 (2020 EVERGREEN INCREASE) 0001564590-20-013212 333-237407 20746380 33 166898
2020-03-26 10-K 10-K 0001564590-20-013207 001-38692 20746338 34 10517124 1
2020-03-26 8-K 8-K FYE 12.31.19 2.02,9.01 0001564590-20-013200 001-38692 20746247 34 472275
2020-02-19 4 FORM 4 SUBMISSION 0001209191-20-010740 5361
2020-02-14 SC 13G/A SC 13G/A 0001104659-20-021665 005-90684 20619392 34 182099
2020-01-29 SC 13G/A equillium13ga1_123119.htm 0001040188-20-000012 005-90684 20557197 34 43919
2020-01-22 4 FORM 4 SUBMISSION 0001209191-20-004544 5570
2020-01-02 3 FORM 3 SUBMISSION 0001209191-20-000409 9993
2019-12-12 4 FORM 4 SUBMISSION 0001209191-19-060275 5427
2019-12-12 4 FORM 4 SUBMISSION 0001209191-19-060272 5433
2019-12-12 4 FORM 4 SUBMISSION 0001209191-19-060270 5422
2019-12-12 4 FORM 4 SUBMISSION 0001209191-19-060269 5402
2019-12-12 4 FORM 4 SUBMISSION 0001209191-19-060268 5442
2019-12-12 8-K 8-K 1.01,5.02,8.01,9.01 0001193125-19-312050 001-38692 191281033 34 71432
2019-11-27 8-K 8-K 8.01 0001193125-19-302509 001-38692 191257899 34 17880
2019-11-25 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2019-11-25 16:30:00 9999999995-19-002656 333-234683 191247517 33 1708
2019-11-21 CORRESP filename1.htm 0001193125-19-297572 10511
2019-11-20 UPLOAD filename1.pdf 0000000000-19-015686 39866

Latest XBRL company facts

One latest value per concept from companyfacts (278 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 82.32M 2026-11-10 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
dei EntityPublicFloat Entity Public Float USD 7.10M 2025-06-30 2025 FY 10-K 2026-03-25 0001193125-26-124143
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 2.47M 2025-01-01 2025-12-31 DEF 14A 2026-04-15 0001193125-26-156092
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.40M 2025-01-01 2025-12-31 DEF 14A 2026-04-15 0001193125-26-156092
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 4.48M 2025-01-01 2025-12-31 DEF 14A 2026-04-15 0001193125-26-156092
ecd PeoTotalCompAmt PeoTotalCompAmt USD 4.26M 2025-01-01 2025-12-31 DEF 14A 2026-04-15 0001193125-26-156092
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 146.23 2025-01-01 2025-12-31 DEF 14A 2026-04-15 0001193125-26-156092
ffd NetFeeAmt NetFeeAmt USD 4,090.53 2026-11-12 S-3 2026-11-12 0001193125-26-458652
ffd TtlFeeAmt TtlFeeAmt USD 4,090.53 2026-11-12 S-3 2026-11-12 0001193125-26-458652
ffd TtlOfferingAmt TtlOfferingAmt USD 47.02M 2026-11-12 S-3 2026-11-12 0001193125-26-458652
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-11-12 S-3 2026-11-12 0001193125-26-458652
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-11-12 S-3 2026-11-12 0001193125-26-458652
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 677,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-045726
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 14,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 564,000 2023-09-30 2023 Q3 10-Q 2023-11-08 0000950170-23-061108
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 1.69M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 562,000 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 367,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 283.10M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 1.26M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD 53,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-25 0000950170-24-035919
us-gaap AdjustmentsToAdditionalPaidInCapitalStockSplit Adjustments to Additional Paid in Capital, Stock Split USD 197 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-27 0001564590-19-009580
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 266,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-24 0001564590-21-015103
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 3.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-045726
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-045726
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 15.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap Assets Assets USD 55.81M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap AssetsCurrent Assets, Current USD 54.95M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 52.37M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 3,000 2024-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 0 2024-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 4.49M 2024-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 0 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 4.49M 2024-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets USD 734,000 2022-02-14 2022 Q3 10-Q 2022-11-14 0000950170-22-025052
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents USD 700,000 2022-02-14 2022 Q3 10-Q 2022-11-14 0000950170-22-025052
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets USD 28,000 2022-02-14 2022 Q3 10-Q 2022-11-14 0000950170-22-025052
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable USD 265,000 2022-02-14 2022 Q3 10-Q 2022-11-14 0000950170-22-025052
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities USD 1.24M 2022-02-14 2022 Q3 10-Q 2022-11-14 0000950170-22-025052
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net USD 507,000 2022-02-14 2022 Q3 10-Q 2022-11-14 0000950170-22-025052
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets USD 6,000 2022-02-14 2022 Q3 10-Q 2022-11-14 0000950170-22-025052
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 71,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-13 0001193125-26-221625
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 700,000 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-08 0000950170-23-061108
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 53.32M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 22.60M 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-045726
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 28.51M 2018-12-31 2018 FY 10-K 2019-03-27 0001564590-19-009580
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 53.32M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 23.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 101.30M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 400.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 63.41M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 63.41M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap CommonStockValue Common Stock, Value, Issued USD 5,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -14.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 6.99M 2017-12-31 2018 FY 10-K 2019-03-27 0001564590-19-009580
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 340,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 0 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-25 0000950170-24-035919
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 21,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 12.30M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013207
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 36,000 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021236
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 58,000 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-11-10 0001564590-20-052979
us-gaap DebtSecuritiesRealizedGainLoss Debt Securities, Realized Gain (Loss) USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004407
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-25 0000950170-24-035919
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 163,000 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 1.33M 2018-09-30 2018 Q3 10-Q 2018-11-15 0001564590-18-029687
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 15.73M 2023-12-31 2024 FY 10-K 2025-03-27 0000950170-25-045726
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 10.38M 2022-12-31 2023 FY 10-K 2024-03-25 0000950170-24-035919
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 12.75M 2023-12-31 2024 FY 10-K 2025-03-27 0000950170-25-045726
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 108,000 2021-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004407
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 54.86M 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2022-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009492
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 163,000 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 33.98M 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 139.80M 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 92.10M 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 1.56M 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 10.95M 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation USD 2.38M 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-045726
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 54.70M 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 138,000 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 25,000 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 272 2018-12-31 2018 FY 10-K 2019-03-27 0001564590-19-009580
us-gaap DeferredTaxLiabilitiesTaxDeferredIncome Deferred Tax Liabilities, Tax Deferred Income USD 945,000 2022-12-31 2023 FY 10-K 2024-03-25 0000950170-24-035919
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap Depreciation Depreciation USD 74,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 93,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-08 0000950170-23-061108
us-gaap Dividends Dividends USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-27 0001564590-19-009580
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.14 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.17 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009669
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.14 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.179 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-27 0001564590-19-009580
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.066 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.055 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD -35,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 1.39M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 3.80M 2024-09-30 2024 Q3 10-Q 2024-11-13 0000950170-24-126322
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 12.70M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap EquityMethodInvestmentOtherThanTemporaryImpairment Equity Method Investment, Other than Temporary Impairment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap FairValueLiabilitiesLevel1ToLevel2TransfersAmount Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount USD 0 2019-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013207
us-gaap FairValueLiabilitiesLevel2ToLevel1TransfersAmount Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount USD 0 2019-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013207
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013207
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013207
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 775,842 2017-12-31 2018 FY 10-K 2019-03-27 0001564590-19-009580
us-gaap FairValueOfAssetsAcquired Fair Value of Assets Acquired USD 23.05M 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-08 0000950170-23-061108
us-gaap FederalIncomeTaxExpenseBenefitContinuingOperations Federal Income Tax Expense (Benefit), Continuing Operations USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -100,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009669
us-gaap ForeignCurrencyTransactionGainLossUnrealized Foreign Currency Transaction Gain (Loss), Unrealized USD -64,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -19,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -19,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap GainOnSaleOfInvestments Gain on Sale of Investments USD 13,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004407
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 7.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap IncomeLossAttributableToParent Income (Loss) Attributable to Parent, before Tax USD -22.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -21.57M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -22.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -827,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -29.81M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-24 0001564590-21-015103
us-gaap IncomeTaxesPaid Income Taxes Paid USD 580,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0000950170-25-045726
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 352,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 4.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD -198,687 2017-03-16 2017-12-31 2018 FY 10-K 2019-03-27 0001564590-19-009580
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 488,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -4.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 4.84M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-25 0000950170-24-035919
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.47M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -20,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 564,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 1.23M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -85,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -3.73M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -135,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -15.73M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -69,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009669
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 874,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap InterestExpenseDebt Interest Expense, Debt USD 491,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0000950170-25-045726
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 946,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0000950170-25-045726
us-gaap InterestPayableCurrent Interest Payable, Current USD 74,000 2022-12-31 2023 FY 10-K 2024-03-25 0000950170-24-035919
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 1.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap InvestmentsFairValueDisclosure Investments, Fair Value Disclosure USD 10.43M 2024-09-30 2024 Q3 10-Q 2024-11-13 0000950170-24-126322
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 796,000 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 28,000 2021-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004407
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 421,000 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 28,000 2022-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009492
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 28,000 2023-12-31 2023 FY 10-K 2024-03-25 0000950170-24-035919
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 5,000 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 370,000 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 123,000 2024-09-30 2024 Q3 10-Q 2024-11-13 0000950170-24-126322
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 77,000 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap Liabilities Liabilities USD 3.13M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 55.81M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 507,000 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-08 0000950170-23-061108
us-gaap LiabilitiesCurrent Liabilities, Current USD 2.82M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 163,000 2019-06-30 2019 Q2 10-Q 2019-08-12 0001564590-19-031483
us-gaap LitigationSettlementExpense Litigation Settlement, Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap LongTermDebt Long-term Debt USD 7.64M 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021236
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 5.71M 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021236
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 1.84M 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021236
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 3.24M 2022-12-31 2023 FY 10-K 2024-03-25 0000950170-24-035919
us-gaap LossOnSaleOfInvestments Loss on Sale of Investments USD 0 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-11-10 0001564590-20-052979
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 35.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -74,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -12.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -14.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 57,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-056960
us-gaap NotesPayable Notes Payable USD 9.00M 2022-12-31 2023 FY 10-K 2024-03-25 0000950170-24-035919
us-gaap NotesPayableCurrent Notes Payable, Current USD 5.71M 2022-12-31 2023 FY 10-K 2024-03-25 0000950170-24-035919
us-gaap NotesPayableRelatedPartiesNoncurrent Notes Payable, Related Parties, Noncurrent USD 1.06M 2017-12-31 2018 FY 10-K 2019-03-27 0001564590-19-009580
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap OperatingExpenses Operating Expenses USD 15.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -15.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap OperatingLeaseCost Operating Lease, Cost USD 500,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 400,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0000950170-24-126322
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 719,000 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 452,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 313,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap OperatingLeasePayments Operating Lease, Payments USD 244,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 671,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 1.89M 2021-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004407
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 510,000 2021-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004407
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 169,000 2021-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004407
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 192,000 2021-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004407
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 492,000 2021-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004407
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 494,000 2021-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004407
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 28,000 2021-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004407
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 300,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004407
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.097 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 139.80M 2018-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 175,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap OtherAssetsCurrent Other Assets, Current USD 214,000 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 27,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 4,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 4,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD 16,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013207
us-gaap OtherIncome Other Income USD -82,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 54,000 2020-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004407
us-gaap OtherNoncashExpense Other Noncash Expense USD 19,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042933
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 20,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013207
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -382,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-056960
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 144,000 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 108,000 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 615,091 2017-03-16 2017-12-31 2018 FY 10-K 2019-03-27 0001564590-19-009580
us-gaap OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings USD 0 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-056960
us-gaap OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net, Available-for-sale Securities USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0000950170-21-004079
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 2.56M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013207
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 260,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0000950170-25-045726
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 2.12M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013207
us-gaap PaymentsToAcquireMachineryAndEquipment Payments to Acquire Machinery and Equipment USD 3,000 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-08 0000950170-23-061108
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 74,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 17.60M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 1.63M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap PrepaidInsurance Prepaid Insurance USD 295,000 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 1.60M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013207
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 9.88M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-24 0001564590-21-015103
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 64.47M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013207
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 35.76M 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-10 0000950170-21-004079
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 34.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 20.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments Proceeds from Maturities, Prepayments and Calls of Short-term Investments USD 4.50M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 1.00M 2017-03-16 2017-12-31 2018 FY 10-K 2019-03-27 0001564590-19-009580
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesEquity Proceeds from Sale of Available-for-sale Securities, Equity USD 15.00M 2017-05-01 2017-05-31 2019 Q3 10-Q 2019-11-12 0001564590-19-042933
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 12,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 582,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 86,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-08 0000950170-23-061108
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -14.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap PropertyPlantAndEquipmentDisposals Property, Plant and Equipment, Disposals USD 31,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 164,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 9.13M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0000950170-25-045726
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 37.04M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-25 0000950170-24-035919
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 8.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 23.05M 2022-01-01 2022-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021236
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -230.79M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 41.09M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 287,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 3.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.394 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.04 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.029 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-15 0001564590-18-029687
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.028 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-15 0001564590-18-029687
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 1.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.33 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 1.48M 2020-04-22 2020 FY 10-K 2021-03-24 0001564590-21-015103
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 1.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap SharePrice Share Price USD/shares 3.38 2019-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013207
us-gaap StateAndLocalIncomeTaxExpenseBenefitContinuingOperations State and Local Income Tax Expense (Benefit), Continuing Operations USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 52.68M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap StockIssued1 Stock Issued USD 22.54M 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-08 0000950170-23-061108
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 12.30M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013207
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 7,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 252,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-23 0000950170-22-004407
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 29.91M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-23 0000950170-23-009492
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 135,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 260,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0000950170-25-045726
us-gaap StraightLineRent Straight Line Rent USD -2,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013207
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 7.19M 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 11,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013207
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 271,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 600,000 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 3.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap VariableLeaseCost Variable Lease, Cost USD 300,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001193125-26-124143
us-gaap WarrantsNotSettleableInCashFairValueDisclosure Warrants Not Settleable in Cash, Fair Value Disclosure USD 300,000 2019-09-30 2021 FY 10-K 2022-03-23 0000950170-22-004407
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 106.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 31.87M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009669
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 106.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458443

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →